Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex
- PMID: 17492593
- DOI: 10.1086/518043
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex
Abstract
The light subunit of neurofilament protein (NFL) is a sensitive indicator of central nervous system axonal injury. We retrospectively identified 9 subjects participating in a longitudinal cohort study who developed acquired immunodeficiency syndrome dementia complex (ADC) and who had had a lumbar puncture performed within 2 years before presentation. Elevated cerebrospinal fluid (CSF) NFL concentrations were found in 7 (78%) of the 9 case patients who later developed ADC, compared with 9 (33%) of 27 CD4 cell count-matched HIV-1-infected control subjects. By contrast, no differences were found in CSF HIV-1 RNA or neopterin concentrations between the 2 groups. CSF NFL may prove to be a useful predictive marker for ADC.
Similar articles
-
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.Neurology. 2007 Oct 9;69(15):1536-41. doi: 10.1212/01.wnl.0000277635.05973.55. Neurology. 2007. PMID: 17923616
-
Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.Ann Neurol. 1990 Oct;28(4):556-60. doi: 10.1002/ana.410280413. Ann Neurol. 1990. PMID: 2252366
-
Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.AIDS. 1993 May;7(5):669-75. AIDS. 1993. PMID: 8318174
-
[The human immunodeficiency virus type 1 and the developing central nervous system].Biomedica. 2005 Mar;25(1):136-47. Biomedica. 2005. PMID: 15962910 Review. Spanish.
-
Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system.Res Publ Assoc Res Nerv Ment Dis. 1994;72:1-45. Res Publ Assoc Res Nerv Ment Dis. 1994. PMID: 8115708 Review. No abstract available.
Cited by
-
Blood Biomarkers of Neuronal/Axonal and Glial Injury in Human Immunodeficiency Virus-Associated Neurocognitive Disorders.Dement Geriatr Cogn Disord. 2022;51(6):467-474. doi: 10.1159/000527659. Epub 2023 Feb 6. Dement Geriatr Cogn Disord. 2022. PMID: 36746132 Free PMC article.
-
Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.J Neuroimmune Pharmacol. 2013 Dec;8(5):1147-58. doi: 10.1007/s11481-013-9491-3. Epub 2013 Aug 13. J Neuroimmune Pharmacol. 2013. PMID: 23943280 Free PMC article. Review.
-
HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.Curr HIV/AIDS Rep. 2014 Sep;11(3):317-24. doi: 10.1007/s11904-014-0221-0. Curr HIV/AIDS Rep. 2014. PMID: 24966139 Review.
-
HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.F1000Res. 2017 Mar 23;6:312. doi: 10.12688/f1000research.10651.1. eCollection 2017. F1000Res. 2017. PMID: 28413625 Free PMC article. Review.
-
HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives.Trop Med Infect Dis. 2025 Feb 5;10(2):45. doi: 10.3390/tropicalmed10020045. Trop Med Infect Dis. 2025. PMID: 39998049 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials